These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 29214751

  • 1. Multi-center Performance Evaluations of Tacrolimus and Cyclosporine Electrochemiluminescence Immunoassays in the Asia-Pacific Region.
    Qin X, Rui J, Xia Y, Mu H, Song SH, Raja Aziddin RE, Miles G, Sun Y, Chun S.
    Ann Lab Med; 2018 Mar; 38(2):85-94. PubMed ID: 29214751
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the New Cyclosporine and Tacrolimus Automated Electrochemiluminescence Immunoassays under Field Conditions.
    Toole B, Gechtman C, Dreier J, Kuhn J, Gutierrez MR, Barrett A, Niederau C.
    Clin Lab; 2015 Mar; 61(9):1303-15. PubMed ID: 26554251
    [Abstract] [Full Text] [Related]

  • 3. Accuracy evaluation of Roche and Siemens tacrolimus and cyclosporine assays in comparison with liquid chromatography-tandem mass spectrometry.
    Ko DH, Cho EJ, Lee W, Chun S, Min WK.
    Scand J Clin Lab Invest; 2018 Oct; 78(6):431-438. PubMed ID: 30270673
    [Abstract] [Full Text] [Related]

  • 4. Multi-center analytical evaluation of a novel automated tacrolimus immunoassay.
    Shipkova M, Vogeser M, Ramos PA, Verstraete AG, Orth M, Schneider C, Wallemacq P.
    Clin Biochem; 2014 Aug; 47(12):1069-77. PubMed ID: 24721684
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of electrochemiluminescence immunoassays for immunosuppressive drugs on the Roche cobas e411 analyzer.
    Fung AWS, Knauer MJ, Blasutig IM, Colantonio DA, Kulasingam V.
    F1000Res; 2017 Aug; 6():1832. PubMed ID: 29225777
    [Abstract] [Full Text] [Related]

  • 6. Inter-laboratory Variability of Current Immunoassay Methods for Tacrolimus among Japanese Hospitals.
    Miura M, Masuda S, Egawa H, Yuzawa K, Matsubara K.
    Biol Pharm Bull; 2016 Aug 01; 39(8):1331-7. PubMed ID: 27263473
    [Abstract] [Full Text] [Related]

  • 7. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
    Wallemacq P, Goffinet JS, O'Morchoe S, Rosiere T, Maine GT, Labalette M, Aimo G, Dickson D, Schmidt E, Schwinzer R, Schmid RW.
    Ther Drug Monit; 2009 Apr 01; 31(2):198-204. PubMed ID: 19258928
    [Abstract] [Full Text] [Related]

  • 8. Performance of the Dimension TAC assay and comparison of multiple platforms for the measurement of tacrolimus.
    Cho EJ, Ko DH, Lee W, Chun S, Lee HK, Min WK.
    J Clin Lab Anal; 2018 May 01; 32(4):e22357. PubMed ID: 29148096
    [Abstract] [Full Text] [Related]

  • 9. Analytical performance evaluation of the Elecsys® Cyclosporine and Elecsys® Tacrolimus assays on the cobas e411 analyzer.
    Sasano M, Kimura S, Maeda I, Hidaka Y.
    Pract Lab Med; 2017 Aug 01; 8():10-17. PubMed ID: 28856221
    [Abstract] [Full Text] [Related]

  • 10. Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole Blood.
    Verstraete AG, Rigo-Bonnin R, Wallemacq P, Vogeser M, Schuetzenmeister A, Schmiedel C, Shipkova M.
    Ther Drug Monit; 2018 Feb 01; 40(1):59-68. PubMed ID: 29210975
    [Abstract] [Full Text] [Related]

  • 11. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E, Bonardet A, Pageaux GP, Mourad G, Cristol JP.
    Transplant Proc; 2009 Mar 01; 41(2):707-9. PubMed ID: 19328963
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous determination of cyclosporine and tacrolimus in human whole blood by ultra-high performance liquid chromatography tandem mass spectrometry and comparison with a chemiluminescence microparticle immunoassay.
    Mei S, Wang J, Chen D, Zhu L, Zhao M, Tian X, Hu X, Zhao Z.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun 15; 1087-1088():36-42. PubMed ID: 29704799
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multicenter analytical evaluation of the automated electrochemiluminescence immunoassay for cyclosporine.
    Vogeser M, Shipkova M, Rigo-Bonnin R, Wallemacq P, Orth M, Widmann M, Verstraete AG.
    Ther Drug Monit; 2014 Oct 15; 36(5):640-50. PubMed ID: 24646730
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of 2 immunoassays for monitoring low blood levels of tacrolimus.
    Amann S, Parker TS, Levine DM.
    Ther Drug Monit; 2009 Apr 15; 31(2):273-6. PubMed ID: 19142177
    [Abstract] [Full Text] [Related]

  • 16. Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzer.
    Griffey MA, Hock KG, Kilgore DC, Wei TQ, Duh SH, Christenson R, Scott MG.
    Clin Chim Acta; 2007 Sep 15; 384(1-2):48-51. PubMed ID: 17588555
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C, Guinedor A, Barau C, Gozalo C, Grimbert P, Duvoux C, Furlan V, Massias L, Hulin A.
    J Pharm Biomed Anal; 2010 Dec 01; 53(4):997-1002. PubMed ID: 20674215
    [Abstract] [Full Text] [Related]

  • 19. Comparison of 4 Commercial Immunoassays Used in Measuring the Concentration of Tacrolimus in Blood and Their Cross-Reactivity to Its Metabolites.
    Shigematsu T, Suetsugu K, Yamamoto N, Tsuchiya Y, Masuda S.
    Ther Drug Monit; 2020 Jun 01; 42(3):400-406. PubMed ID: 31568181
    [Abstract] [Full Text] [Related]

  • 20. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
    Koster RA, Dijkers EC, Uges DR.
    Ther Drug Monit; 2009 Feb 01; 31(1):116-25. PubMed ID: 19065123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.